LiqTech International, Inc. (NYSE:LIQT) tinted loss of -1.75% (-0.04 points) to US$2.24. The volume of 0.54 Million shares climbed down over an trading activity of 681.65 Million shares. EPS ratio determined by looking at last 12 month figures is -0.07. Over the same time span, the stock marked US$2.38 as its best level and the lowest price reached was US$0.31. The corporation has a market cap of US$164.06 Million.
LiqTech International, Inc. (NYSE:LIQT)’s earnings per share has been growing at a 1.8 percent rate over the past 5 year when average revenue increase was noted as -7.7 percent. The return on equity ratio or ROE stands at -44.8 percent while most common profitability ratio return on investment (ROI) was -62.2 percent. The company’s institutional ownership is monitored at 25.9 percent. The company’s net profit margin has achieved the current level of -29.8 percent and possesses 7.7 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 2. 3 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
ArQule, Inc. (NASDAQ:ARQL) is worth US$366.15 Million and has recently fallen -9.72% to US$3.25. The latest exchange of 1.1 Million shares is above its average trading activity of 1.02 Million shares. The day began at US$3.62 but the price moved to US$3.3 at one point during the trading and finally capitulating to a session high of US$3.62. The stock tapped a 52-week high of US$7.21 while the mean 12-month price target for the shares is US$7.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 4.01, and a price to sales ratio of 16.06. For the past 5 years, the company’s revenue has grown 0%, while the company’s earnings per share has grown -16.5%. With an institutional ownership near 81%, it carries an earnings per share ratio of -0.17.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 2 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 5 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.71.